Web Exclusives - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Web Exclusives

Sidewiki: What's Pharma to Do?

October 28, 2009

Google opened up a whole new era of social media when it released Sidewiki - a tool that allows anyone to comment on any Web site. Now pharma has a new battle to fight.

What's the best managed pharma company? Find out in the Industry Audit and Company of the Year Podcast

October 21, 2009

Industry Audit and Company of The year.

Pharma's Emerging Leaders - Podcast series

October 19, 2009

Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success.

Biomarkers: Promises and Challenges

October 14, 2009

Jerome Wilson and Martin Nemansky, explore some of the difficulties of implementing biomarkers during drug development.

Action Amid Uncertainty: Preparing for Health Reform

October 14, 2009

As the health care reform debate continues to rage on Capitol Hill, pharma companies should be engaged in intense strategic planning for the future. Putting together a game plan now for the most likely reform scenarios will help companies to stay ahead of the curve.

Cut the Cord and Take to the Cloud

October 14, 2009

One feature that should be considered when looking for a new software-as-a-service (SaaS) system is multi-tenancy, which is a chief characteristic of a mature cloud computing application. Here?s what to look for.

The Changing Pharmaceutical Sales Landscape

October 7, 2009

Sales forces can achieve compliance and excellence through individual behavioral fine-tuning and company-wide cultural adjustment.

UK Pharmacies Dealing with Drug Shortages

September 9, 2009

With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?

This Is Going to Hurt

August 12, 2009

The President and Congress are sounding the alarm on the need for healthcare reform. There are several near-certainties for which pharmaceutical and biotechnology companies must be prepared as they develop forecasts and for the next five or six years.

ADVERTISEMENT

Click here